Stanford University — Coronavirus Drug Research (June 2020) (Jeffrey Glenn)

Organization Name 
Award Date 
6/2020
Grant Amount 
$2,531,000
Purpose 
To support work to test an antiviral drug candidate against COVID-19 and other viruses.
Topic (focus area) 

Grant investigators: Chris Somerville and Heather Youngs

This page was reviewed but not written by the grant investigators. Stanford University staff also reviewed this page prior to publication.

Open Philanthropy recommended a grant of $2,531,000 over three years to Stanford University to support work led by Professor Jeffrey Glenn to test an antiviral drug candidate against COVID-19 and a number of other viruses. Professor Glenn plans to use this funding to conduct toxicity and efficacy tests and to have a supply of the drug synthesized for use in future trials.

This follows our February 2020 support and falls within our work on scientific research, specifically within our interest in science supporting biosecurity and pandemic preparedness.